Daniel Ghinn· @creationdaniel · X·· 2 days agoScore70
Body · original
During the NATALEE readout, it's the top trending trial in the live HCP conversation at #ESMO26.
For the first time, you can track how HCPs are reacting to trial data as it happens.
Stop by stand 1060a to try it for yourself.
39 views · 1 like · 0 reposts · 0 replies
Conference abstracts
LBA25matched by Proffered paper 1: Breast cancer, early and advanced stage
Adjuvant ribociclib (RIB) + nonsteroidal aromatase inhibitor (NSAI) in patients (pts) with HR+/HER2− early breast cancer (EBC): NATALEE 6-y overall survival (OS) and efficacy outcomes
https://esmocongress.esmo.orgSource: Daniel Ghinn · x.com